Inspire Medical Systems Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Inspire Medical Systems Inc 's ROA in the second quarter of 2026?
Inspire Medical Systems inc achieved a return on average assets (ROA) of 15.31 % in its second quarter of 2026, this is above INSP's average return on assets of -8.1%.
Inspire Medical Systems Inc assets over the 12 months ending in its second quarter of 2026 are valued at $882 million

ROA fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

However, within the Healthcare sector 64 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 310 to 343.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	18.82 %	24.71 %	-21.38 %	1.02 %	10.19 %
Y / Y Net Income Change	-	-	286.36 %	-46.3 %	-
Net Income (TTM) in million	135	131	145	45	53
Return On Assets (TTM)	15.31 %	15.51 %	18.17 %	5.17 %	6.18 %
INSP's Total Ranking	# 343	# 310	# 1078	# 923	# 723
Total Assets (TTM) in million	926	911	907	784	779
Seq. Total Assets Change	1.6 %	0.45 %	15.68 %	0.65 %	6.63 %
Seq. Net Income Change	-	-	1270.22 %	-	-

INSP's 5 Years Annual ROA >> Back to INSP Management Effectiveness >> Compare INSP ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 65
Overall	# 342

Return On Assets Statistics
High	Average	Low
17.91 %	-8.1 %	-28.28 %
(Dec 31 2025)

Financial Statements
Inspire Medical Systems Inc 's Assets	$ 926 million	INSP's Balance sheet
Inspire Medical Systems Inc 's Income	$ 0 million	Quarterly INSP's Income Statement
INSP's Income by Division		See INSP's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	27.41 %	20.1 %	17.48 %	92.54 %	4.61 %
Total Assets in million	1,004	788	656	558	290
Y / Y Net Income Change	171.77 %	-	-	-	-
Net Income in million	145	54	-21	-45	-42
Annual Return On Assets	14.49 %	6.79 %	-3.23 %	-8.04 %	-14.5 %

INSP's 5 Years Annual ROA >> Back to INSP Management Effectiveness >> Compare INSP ROA to its Competitors

Comment on INSP's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 14.49 % compared to prior year, due to annual net income growth of 171.77 % to $145.42 million, while value of Inspire Medical Systems Inc 's overall assets grew just by 27.41 % to $1,003.65 million, compared to $1,003.65 a year before.

More Return On Assets Ratios
INSP's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
INSP's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for INSP's Competitors
Subscribers only: Roa for Inspire Medical Systems Inc 's Suppliers
Subscribers only: Return On Assets for INSP's Customers

You may also want to know
INSP's Roi	INSP's Inventory Turnover Ratio	INSP's Growth Rates	INSP's Dividend Comparisons
	INSP's Profitability Ratios	INSP's Asset Turnover Ratio	INSP's Dividend Growth
INSP's Roe	INSP's Valuation Ratios	INSP's Financial Strength Ratios	INSP's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Liquidia Corporation	36.30 %
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %

Date modified: 2026-09-13T23:43:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.